vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	9.45	12.13	13.42	5.75	1.78
Short-Term Investments	0	12.24	0	0	0
Cash & Cash Equivalents	9.45	24.37	13.42	5.75	1.78
Cash Growth	-61.24%	81.65%	133.43%	223.41%	5.59%
Receivables	0.1	0.17	0.06	0.16	0.01
Other Current Assets	1.11	2.55	2.15	1.31	1.06
Total Current Assets	10.66	27.09	15.62	7.22	2.84
Property, Plant & Equipment	0.36	0.56	0.68	0.85	1
Long-Term Investments	0	5.59	9.17	6.73	5.42
Total Long-Term Assets	0.36	6.14	9.85	7.57	6.43
Total Assets	11.02	33.24	25.47	14.79	9.27
Accounts Payable	10.24	7.31	8.02	6.12	7.07
Current Debt	0.36	0.38	0.44	0.24	6.28
Other Current Liabilities	0.02	0.02	0.04	0.03	0.03
Total Current Liabilities	10.62	7.71	8.5	6.39	13.38
Long-Term Debt	0.17	0.34	0.49	0.68	0.83
Other Long-Term Liabilities	18.78	19.35	1.26	3.93	3.89
Total Long-Term Liabilities	18.95	19.69	1.75	4.61	4.73
Total Liabilities	29.57	27.4	10.25	11	18.11
Total Debt	0.53	0.72	0.93	0.92	7.11
Debt Growth	-26.12%	-23.18%	1.86%	-87.14%	-54.73%
Retained Earnings	-281.04	-265.52	-248.83	-290.04	-233.52
Shareholders' Equity	-24.68	-10.74	-9.74	-80.1	-49.02
Net Cash / Debt	8.92	23.65	12.48	4.83	-5.34
Net Cash / Debt Growth	-62.30%	89.48%	158.34%	-	-
Working Capital	0.04	19.39	7.12	0.83	-10.54
Book Value Per Share	-9.44	-4.11	-4.33	-43.37	-32.73

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).